You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


CHMP gives positive opinion recommending authorisation to GSK’s CKD drug

Global biopharmaceutical company GSK has announced that EMA’s CHMP has given its drug treatment for symptomatic anaemia associated with chronic kidney disease (CKD) in adults on chronic maintenance dialysis a positive recommendation for authorisation.